OrthoPediatrics Corp.

OrthoPediatrics Corp.

KIDS
OrthoPediatrics Corp.US flagNASDAQ Global Market
24.80
USD
-0.21
- -
636.99MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.18
4.13
4.96
9.47
4.58
4.96
3.94
5.09
5.91
6.56
8.87
10.07
10.66
Basic EPS, GAAP
-1.28
-1.69
-1.66
-4.88
-0.96
-0.94
-1.82
-0.84
0.06
-0.92
-1.64
-1.69
-1.67
Free Cash Flow per Basic Share
-1.78
-0.42
-0.78
-2.86
-1.67
-2.04
-1.65
-1.51
-1.54
-2.03
-1.79
-0.68
-0.08
Dividend per Share
- -
- -
- -
1.24
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-3.54
-4.49
-5.42
3.76
5.62
8.51
12
11.45
16.55
16.13
14.64
13.81
13.16
Tangible Book Value per Share
-3.61
-4.57
-5.53
3.58
5.47
6.55
5.11
4.23
9.26
8.93
7.41
6.36
5.69
Basic Weighted Avg Shares
7
8
8
5
13
15
18
19
21
23
23
23
24
Sales/Revenue/Turnover
24
31
37
46
58
73
71
98
122
149
205
236
253
Operating Margin (%)
-30.16
-21.26
-16.43
-14.19
-16.6
-12.51
-28.72
-18.23
-17.82
-17.32
-14.42
-12.27
-9.01
Depreciation Expense
2
2
2
2
3
5
8
11
13
17
19
21
22
Net Income, GAAP
-10
-8
-7
-9
-12
-14
-33
-16
1
-21
-38
-40
-40
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-40.32
-25.45
-17.62
-19.58
-20.89
-18.93
-46.35
-16.58
1.03
-14.1
-18.47
-16.78
-15.72
Working Capital
24
16
14
60
88
114
123
104
196
185
203
210
200
LT Debt
13
13
17
25
21
26
1
1
1
10
73
100
99
Total Equity
18
11
6
47
82
142
235
225
379
377
355
347
344
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-18.61
-12.25
-17.47
-7.07
0.42
-5.55
-10.34
-11.31
-11.36

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
100
100
99
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
26
26
Market Capitalization
446
406
500

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
256
246
253
Cash, Cash Equivalents & STI
61
49
46
Accounts Receivable, Net
54
54
61
Inventories
134
134
138
Total Current Liabilities
46
47
53
Payables & Accruals
29
22
23
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
91.19%
11.07%
-2.25%
Free Cash Flow
29.58%
-4%
-61.36%
Net Income, GAAP
-163.25%
-368.09%
4.83%
Sales/Revenue/Turnover
23.02%
27.48%
15.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
45
53
55
53
205
2025
52
61
61
62
236
2026
59
71
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.34
-0.26
-0.34
-0.69
-1.64
2025
-0.46
-0.3
-0.5
-0.43
-1.69
2026
-0.45
-0.3
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
David R. Bailey
Full Time Employees
602
Sector
Healthcare
Industry
Medical - Devices
Address
2850 Frontier Drive Warsaw IN United States of America 46582
IPO Date
Oct 13, 2017
Business
OrthoPediatrics Corp. is a medical technology enterprise dedicated to the design, development, and commercialization of specialized implants, instruments, and bracing solutions tailored for children confronting orthopedic conditions across the United States and internationally. The company provides a broad range of offerings encompassing trauma and deformity correction, comprehensive scoliosis management including spinal growth guidance systems, and sports medicine procedures. Key product lines include various nailing platforms such as PediNail and PediFlex nail, plate systems like PediPlates, cannulated screws, and advanced solutions such as RESPONSE Spine systems, ApiFix Mid-C System, and the recently introduced VerteGlide Spinal Growth Guidance System. Additionally, its OrthoPediatrics Specialty Bracing (OPSB) division expands its non-surgical solutions. Serving the distinct pediatric orthopedic market, the company partners with pediatric orthopedic surgeons and caregivers. Founded in 2006, OrthoPediatrics Corp. maintains its headquarters in Warsaw, Indiana.

Company News

APIChatGPT
  • OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter

  • Intercontinental Exchange Reports July 2026 Statistics

  • OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript

  • OrthoPediatrics Q2 Earnings Call Highlights

  • OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

  • OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

  • Intercontinental Exchange Approves Third Quarter Dividend of $0.52 per Share

  • Intercontinental Exchange to Acquire MarketAxess, Creating a Premier Fixed Income Marketplace

  • OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

  • ICE First Look at Mortgage Performance: New Default Activity Posts Annual Decline Led by FHA Loans

  • OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026

  • ICE Mortgage Monitor: Gen Z Accounts for Record 1 in 5 Purchase Mortgage Locks

  • Intercontinental Exchange Reports June and Second Quarter 2026 Statistics

  • POTTERY BARN KIDS LAUNCHES NEW COLLABORATION WITH RYLEE + CRU

  • POTTERY BARN KIDS LAUNCHES NEW COLLABORATION WITH BRIA HAMMEL

  • OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children's Hospitals Nationwide

  • OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

  • SOUR PATCH KIDS® BESTIES: A Candy Meant to Be Shared

  • ICE Mortgage Monitor: Home Equity Withdrawals Reach Highest First-Quarter Level Since 2021

  • ICE Benchmark Administration Launches ICE Swap Rate® Inflation Swap Benchmarks in GBP and EUR